Study finds 30.8% of hospitalised COVID patients are obese
An international study examined hospitalised COVID patients across 11 countries - finding that obese patients are 73% more likely to need invasive respiratory support.
Trial finds York/Hull leishmaniasis vaccine is safe
A new vaccine, developed by researchers at the Hull York Medical School, to treat leishmaniasis has proved to be safe in the first clinical trials.
Melting arctic sea ice destroys French wine harvest
Sudden frosts across Europe have hit vineyards hard, with scientists revealing that melting arctic sea ice is responsible for the unpredictable climate.
Regulating all online education providers
The time has come for online education providers to become accredited by the British Government, says David McCarthy, Director of Education at Sophia Technologies.
EU to create new contract with Pfizer for 1.8 billion doses
Yesterday (14 April) EU President Ursula von der Leyen announced that the Commission would create a third contract with Pfizer, for 1.8 billion doses between 2021 to 2023.
84% of young people willing to get vaccinated
Data from a MyVoice national survey has found that the percentage of young people who say they're willing to get vaccinated has risen to 84%.
Reassessing employee engagement strategies
Lucinda Carney, CEO and Founder of Actus Software, discusses the importance of reassessing employee engagement strategies for a virtual workforce.
Altered immune system linked to Long-Covid
Scientists from the University of Manchester have discovered an alteration in the immune system of COVID-19 patients 6 months after hospitalisation, which could be linked to poorer health outcomes.
Prioritising maternal and child health in the COVID-19 era
Mahesh Karra, Assistant Professor of Global Development Policy, discusses the importance of maternal and child health during the COVID pandemic.
European plant-based consumption grows by 49% in two years
Plant-based consumption has increased by 49% in two years across Europe, according to Nielsen data, the first and only report of its kind, published by the Smart Protein project.
The changing face of mobile working in the public sector
Charles Knight, Managing Director of Public Services at Totalmobile, explores what the public sector might look like post-Covid for its mobile workforce.
New study investigates link between COVID-19 and risk of blood clots
People who have recovered from COVID-19 may be at risk of developing blood clots due to an overactive immune response, according to a new study.
New UK study will mix Moderna and Novavax COVID doses
Researchers in the UK started a clinical trial on mixing vaccines in February - today (14 April) a new study will look into mixing Moderna and Novavax doses.
Can we stop young people falling into criminal gangs?
Marco Fiorentino, director of justice & enforcement at Northgate Public Services explores a digital approach to protect young people from crime.
How lockdown travel habits are influencing the green recovery
Mark Nicholson, CEO of Vivacity Labs, discusses how local lockdown travel habits are already influencing the green recovery.
What if there was an ‘Alexa’ for smart infrastructure solutions?
Leading smart infrastructure solutions company Costain discusses the countless benefits of setting up the right data-sharing platform to help organisations transform business performance and meet carbon reduction targets.
Pro-poor policy: What is the role of aspirations failure?
Sayantan Ghosal, Adam Smith Chair in Political Economy, discusses an often-overlooked policy question: What is the relationship between aspiration failure and the continuation of poverty?
Peat soils: Climate killer or climate saver?
Experts in Agricultural and Environmental Sciences Bernd Lennartz, Franziska Tanneberger and Nicole Wrage-Mönnig discuss the complex effects of peat soils on the climate.
Muslims can get COVID vaccine without breaking fast
The NHS said that Muslims can take the COVID vaccine during Ramadan without breaking their fasts, with some centres offering extended opening times.
Asthma drug shortens COVID-19 recovery time
Budesonide, a drug used to treat asthma, has been found to shorten recovery time in COVID-19 patients who are treated at home.
